NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

News

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

News

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

08.25.2021

CBIA BizCast: Funding Alzheimer’s Treatment

CBIA BizCast host Ali Warshavsky speaks with Kristen Cusato,...

Bioscience

08.13.2021

CBIA BizCast: Pfizer’s Groton Location Plays Critical Vaccine Role

CBIA BizCast host Ali Warshavsky speaks with Patti Compton,...

Bioscience

06.18.2021

CBIA BizCast: Wren Laboratories’ Rapid COVID-19 Test

Until the coronavirus pandemic ends, COVID testing will remain...

Bioscience

06.10.2021

A Good Session for Biopharma—So Far

For biopharma, the Connecticut General Assembly is a major...

Bioscience

05.20.2021

Tweed New Haven Airport Expansion Bodes Well for Biotech

Thriving biotech hubs are about collaboration—within companies, but just...

Bioscience

05.19.2021

Drug Price Cap Bill Cripples State’s Biopharma Industry

More than 20 biotech and biopharma companies and organizations,...

Bioscience

04.22.2021

Connecticut Biotech: A Wise Investment

The April issue of The Connecticut Economic Digest examines...

Bioscience

04.09.2021

Drug Price Controls Are ‘Ill-Conceived, Counterproductive’

The bioscience industry has hit back at wide-reaching drug...

Bioscience

03.26.2021

Connecticut Price Controls Will Stifle Biopharma Innovation

A year ago it became clear the novel coronavirus...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.

Economy

HR & Safety

Issues & Policies

Manufacturing

Member News

Media Center

Small Business

Workforce

Take Action

Bioscience

Positive Session for Bioscience Sector

Boehringer Partners on Connecticut Science Center STEM Lab

Costly Public Option Precursor Advances

CBIA BizCast: Funding Alzheimer’s Treatment

CBIA BizCast: Pfizer’s Groton Location Plays Critical Vaccine Role

CBIA BizCast: Wren Laboratories’ Rapid COVID-19 Test

A Good Session for Biopharma—So Far

Tweed New Haven Airport Expansion Bodes Well for Biotech

Drug Price Cap Bill Cripples State’s Biopharma Industry

Connecticut Biotech: A Wise Investment

Drug Price Controls Are ‘Ill-Conceived, Counterproductive’

Connecticut Price Controls Will Stifle Biopharma Innovation

Stay Connected with CBIA News Digests

2025 Manufacturing Tour

Company Name & Address

Company Contact Info